Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADALIMUMAB vs CERTOLIZUMAB PEGOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ADALIMUMAB vs CERTOLIZUMAB PEGOL: Safety Overview

Metric ADALIMUMAB CERTOLIZUMAB PEGOL
Total FAERS Reports 499,856 99,098
Deaths Reported 21,807 5,361
Death Rate 4.4% 5.4%
Hospitalizations 108,264 17,641
Average Patient Age 50.9 yrs 49.5 yrs
% Female Patients 67.6% 83.1%
Manufacturer Coherus BioSciences Inc UCB, Inc.
Route SUBCUTANEOUS SUBCUTANEOUS
Marketing Status Prescription Prescription